جست‌وجوی استاد و پژوهشگر

Smitha Menonمشاهده پروفایل

دانشیار بالینی

• Thoracic Oncology
• Immunotherapy
• Targeted Therapy
• +۴ مورد دیگر

Smitha Menon, M.D., serves as a Clinical Associate Professor in the Division of Hematology and Oncology at the University of Washington and holds a Physician & Research Faculty position at Fred Hutchinson Cancer Center in Seattle, Washington. Her clinical practice is centered at Fred Hutch at UW Medical Center - Montlake, specializing in complex oncology cases. Her academic foundation includes: M.B.B.S. from Stanley Medical College, Chennai, India Residency in Internal Medicine at Mayo Clinic, Rochester, MN Fellowship in Hematology and Oncology at Mayo Clinic, Rochester, MN Dr. Menon maintains board certifications in both Internal Medicine and Oncology through the American Board of Internal Medicine. Her clinical expertise focuses on head and neck cancers and lung cancer, with research centered on thoracic malignancy management using immunotherapy and targeted therapeutic approaches . She actively investigates cancer cachexia and sarcopenia —critical metabolic complications affecting body composition in cancer patients—aiming to develop integrated treatment strategies that address both tumor biology and patient physiology.

Stephan von Haehlingمشاهده پروفایل

استاد

• Heart Failure
• Metabolic Cardiology
• Cardio-Oncology
• +۳ مورد دیگر

Stephan von Haehling is DZHK Professor of Metabolic Cardiology at the University of Göttingen's Faculty of Medicine and Heart Center Göttingen. He serves as spokesperson for the German Society of Cardiology's Heart Failure Working Group and deputy editor of ESC Heart Failure , focusing on clinically relevant heart failure and cardio-oncology research. His primary research examines comorbidities in heart failure, particularly sarcopenia (affecting over 20% of patients) and bone metabolism deterioration. His team demonstrated sarcopenia's role as an independent mortality predictor, leading to its inclusion in European Society of Cardiology guidelines. In cardio-oncology, they investigate cancer-induced cardiovascular changes that impair physical resilience and quality of life, identifying biomarkers like osteoprotegerin and kynurenine for early prediction. Recent publications (2020-2023) emphasize heart failure management during the COVID-19 pandemic, cardio-oncology quality-of-life metrics, bone health in heart failure, and diagnostic biomarkers for acute heart failure. His work combines clinical trials, retrospective analyses, and biomarker validation, significantly influencing European treatment guidelines. Prof. von Haehling leads a research team at Göttingen's Heart Center, conducting translational studies on metabolic cardiology with international collaborations through the German Centre for Cardiovascular Research (DZHK).